cabiralizumab   Click here for help

GtoPdb Ligand ID: 9107

Synonyms: BMS-986227 | FPA-008 | FPA008
Immunopharmacology Ligand
Compound class: Antibody
Comment: Cabiralizumab is an investigational humanized monoclonal antibody targeting the receptor tyrosine kinase, CSF1R (Fms). It is being investigated for its potential anti-cancer activity.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent US20110274683 [1]
Click here for help
1. Wong J, Vasquez M. (2011)
Antibodies That Bind CSF1R.
Patent number: US20110274683 A1. Assignee: Five Prime Therapeutics, Inc.. Priority date: 04/05/2010. Publication date: 10/11/2011.